Bone Marrow Transplantation - Table of Contents alert Volume 51 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 51, Issue 6 (June 2016) In this issue Review Commentaries Original Articles Letters to the Editor Erratum Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Acute kidney injury in HCT: an update J A Lopes, S Jorge and M Neves Bone Marrow Transplant 2016 51: 755-762; advance online publication, February 8, 2016; 10.1038/bmt.2015.357 Abstract | Full Text Commentaries Top Long-term survival of patients with therapy-related myeloid neoplasms after allogeneic hematopoietic cell transplantation—more than just a myth S Mukherjee and A T Gerds Bone Marrow Transplant 2016 51: 763-764; advance online publication, May 9, 2016; 10.1038/bmt.2016.121 Full Text Transplantation in CLL: what we can learn from a dinosaur P Dreger and E Montserrat Bone Marrow Transplant 2016 51: 765-766; advance online publication, February 29, 2016; 10.1038/bmt.2016.27 Full Text The need for ‘onco-nephrology’ is increasing in hematopoietic stem cell transplantation M Ando Bone Marrow Transplant 2016 51: 767-768; advance online publication, March 21, 2016; 10.1038/bmt.2016.68 Full Text CLL: ibrutinib and transplantation ride together E Montserrat and J Delgado Bone Marrow Transplant 2016 51: 769-770; advance online publication, May 9, 2016; 10.1038/bmt.2016.118 Full Text Original Articles Top ACUTE LEUKEMIA Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation J Finke, C Schmoor, H Bertz, R Marks, R Wäsch, R Zeiser and B Hackanson Bone Marrow Transplant 2016 51: 771-777; advance online publication, January 11, 2016; 10.1038/bmt.2015.338 Abstract | Full Text Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey D Niederwieser, H Baldomero, J Szer, M Gratwohl, M Aljurf, Y Atsuta, L F Bouzas, D Confer, H Greinix, M Horowitz, M Iida, J Lipton, M Mohty, N Novitzky, J Nunez, J Passweg, M C Pasquini, Y Kodera, J Apperley, A Seber and A Gratwohl for the Worldwide Network of Blood and Marrow Transplantation (WBMT) Bone Marrow Transplant 2016 51: 778-785; advance online publication, February 22, 2016; 10.1038/bmt.2016.18 Abstract | Full Text Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually OPEN J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J Kuball, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda and M Mohty for the European Society for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2016 51: 786-792; advance online publication, February 22, 2016; 10.1038/bmt.2016.20 Abstract | Full Text CHRONIC LEUKEMIA Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation C S Link, R Teipel, F Heidenreich, E Rücker-Braun, M Schmiedgen, J Reinhardt, U Oelschlägel, M von Bonin, J M Middeke, A Muetherig, K Trautmann-Grill, U Platzbecker, M Bornhäuser and J Schetelig Bone Marrow Transplant 2016 51: 793-798; advance online publication, January 11, 2016; 10.1038/bmt.2015.339 Abstract | Full Text Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study M van Gelder, M H van Oers, W G Alemayehu, M C J Abrahamse-Testroote, J J Cornelissen, M E Chamuleau, P Zachée, M Hoogendoorn, M Nijland, E J Petersen, A Beeker, G-J Timmers, L Verdonck, M Westerman, O de Weerdt and A P Kater Bone Marrow Transplant 2016 51: 799-806; advance online publication, February 15, 2016; 10.1038/bmt.2016.9 Abstract | Full Text LYMPHOMA Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL S H Lim, S H Hyun, H S Kim, J Y Lee, K H Yoo, K S Jung, H-N Song, J Cho, S Park, Y H Ko, S J Kim, J Y Choi and W S Kim Bone Marrow Transplant 2016 51: 807-812; advance online publication, February 8, 2016; 10.1038/bmt.2016.6 Abstract | Full Text INHERITED AND GENETIC DISORDERS Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors U Anurathapan, S Hongeng, S Pakakasama, N Sirachainan, D Songdej, A Chuansumrit, P Charoenkwan, A Jetsrisuparb, K Sanpakit, P Rujkijyanont, A Meekaewkunchorn, Y Lektrakul, P Iamsirirak, P Surapolchai, W Satayasai, S Sirireung, R Sruamsiri, P A Wahidiyat, A Ungkanont, S Issaragrisil and B S Andersson Bone Marrow Transplant 2016 51: 813-818; advance online publication, February 15, 2016; 10.1038/bmt.2016.7 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD A Velasco-Guardado, A Mora-Soler, L López-Corral, O López-Godino, L Vázquez-López, O Blanco-Muñez, E Pérez-López, A Rodríguez-Pérez and D Caballero-Barrigón Bone Marrow Transplant 2016 51: 819-824; advance online publication, March 7, 2016; 10.1038/bmt.2016.31 Abstract | Full Text INFECTIONS Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT OPEN D M Burns, S Rana, E Martin, S Nagra, J Ward, H Osman, A I Bell, P Moss, N H Russell, C F Craddock, C P Fox and S Chaganti Bone Marrow Transplant 2016 51: 825-832; advance online publication, February 22, 2016; 10.1038/bmt.2016.19 Abstract | Full Text QOL AND PATIENTS' CARE Sexual function 1-year after allogeneic hematopoietic stem cell transplantation K H Noerskov, I Schjødt, K L Syrjala and M Jarden Bone Marrow Transplant 2016 51: 833-840; advance online publication, February 15, 2016; 10.1038/bmt.2015.342 Abstract | Full Text Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation S Mayo, H A Messner, S B Rourke, D Howell, J C Victor, J Kuruvilla, J H Lipton, V Gupta, D D Kim, C Piescic, D Breen, A Lambie, D Loach, F V Michelis, N Alam, J Uhm, L McGillis and K Metcalfe Bone Marrow Transplant 2016 51: 841-847; advance online publication, February 29, 2016; 10.1038/bmt.2016.2 Abstract | Full Text Letters to the Editor Top Successful matched sibling cord blood transplant for ALL in a child with constitutional mismatch repair deficiency syndrome J A Heath, M Campbell, K Tiedemann and P A Downie Bone Marrow Transplant 2016 51: 848-849; advance online publication, January 25, 2016; 10.1038/bmt.2015.353 Full Text Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation J A Yared, N Hardy, Z Singh, S Hajj, A Z Badros, M Kocoglu, S Yanovich, E A Sausville, C Ujjani, K Ruehle, C Goecke, M Landau and A P Rapoport Bone Marrow Transplant 2016 51: 850-852; advance online publication, February 1, 2016; 10.1038/bmt.2015.346 Full Text Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT A Vatanen, T H Ojala, T Sarkola, M Turanlahti, T Jahnukainen, U M Saarinen-Pihkala and K Jahnukainen Bone Marrow Transplant 2016 51: 853-855; advance online publication, February 1, 2016; 10.1038/bmt.2015.355 Full Text A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen G O'Kane, D Bracken-Clarke, N Gardiner, G Lee, M Ni Chonghaile, D Power, P A Daly, J McCaffrey, C L Bacon, E Conneally, C Flynn, E Vandenberghe, M J Kennedy, P V Browne, D M O'Donnell and P J Hayden Bone Marrow Transplant 2016 51: 856-859; advance online publication, February 8, 2016; 10.1038/bmt.2015.354 Full Text Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants S Masouridi-Levrat, F Simonetta, Y Beauverd, O Tsopra, Y Tirefort, C Stephan, E Levrat, M Ansari, F Verholen, E Roosnek, J R Passweg and Y Chalandon Bone Marrow Transplant 2016 51: 860-862; advance online publication, February 8, 2016; 10.1038/bmt.2015.356 Full Text Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation M Sarmiento, R Parody, F Márquez-Malaver, I Espigado, J Falantes, T Caballero, C Calderón, M Carmona, J López Haldon and J A Pérez-Simón Bone Marrow Transplant 2016 51: 863-865; advance online publication, February 8, 2016; 10.1038/bmt.2016.8 Full Text Shortened apheresis-based extra-corporeal photochemotherapy for acute refractory GVHD in children: a prospective study A Sauret, N Rabiau, E Rochette, V Grèze, P Halle, M Ouachée, J-H Dalle, E Seror, D Serraz, K Yakouben, D Adjaoud, A Pagnier, A Marie-Cardine-Bobbia, C Oudot, C Curtillet, M Poirée, J Kanold and E Merlin Bone Marrow Transplant 2016 51: 866-868; advance online publication, February 8, 2016; 10.1038/bmt.2016.11 Full Text Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy N Kawashima, Y Inamoto, T Sato, M Nakashima, Y Kagaya, K Watakabe, A Seto, N Fukushima, S Kurahashi, Y Ozawa and K Miyamura Bone Marrow Transplant 2016 51: 869-871; advance online publication, February 15, 2016; 10.1038/bmt.2016.15 Full Text Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation A Badbaran, B Fehse, M Christopeit, T Aranyossy, F A Ayuk, C Wolschke and N Kröger Bone Marrow Transplant 2016 51: 872-873; advance online publication, February 15, 2016; 10.1038/bmt.2016.14 Full Text Chimerism interpretation with a highly sensitive quantitative PCR method: 6 months median latency before chimerism drop below 0.1% D C Vicente, A B A Laranjeira, E C M Miranda, J A Yunes and C A de Souza Bone Marrow Transplant 2016 51: 874-875; advance online publication, February 15, 2016; 10.1038/bmt.2016.5 Full Text Medullar toxicity after prolonged nitrous oxide exposure: an unexpected cause of bone marrow failure post allogeneic transplant A Vozy, M Cohen, M T Rubio, S Rostaing-Rigattieri, M Mohty and A-C Mamez Bone Marrow Transplant 2016 51: 876-878; advance online publication, February 22, 2016; 10.1038/bmt.2015.314 Full Text Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers A Arai, C Sakashita, C Hirose, K-I Imadome, M Yamamoto, M Jinta, S Fujiwara, M Tomita, N Shimizu, T Morio and O Miura Bone Marrow Transplant 2016 51: 879-882; advance online publication, February 22, 2016; 10.1038/bmt.2016.3 Full Text Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus K Arita, J Murakami, A Wada, T Miyazono and T Sugiyama Bone Marrow Transplant 2016 51: 883-884; advance online publication, February 22, 2016; 10.1038/bmt.2016.21 Full Text Innovating consent for pediatric HCT patients J Platt, D B Thiel, S L R Kardia and S W Choi Bone Marrow Transplant 2016 51: 885-888; advance online publication, February 29, 2016; 10.1038/bmt.2016.10 Full Text Erratum Top Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? M C Oliveira, M Labopin, J Henes, J Moore, N Del Papa, A Cras, I Sakellari, R Schroers, H U Scherer, A Cuneo, S Kyrcz-Krzemien, T Daikeler, T Alexander, J Finke, M Badoglio, B Simões, J A Snowden and D Farge for the EBMT Autoimmune Diseases Working Party Bone Marrow Transplant 2016 51: 889; 10.1038/bmt.2016.126 Full Text Corrigendum Top Identification and validation of biomarkers associated with acute and chronic graft versus host disease S S Ahmed, X N Wang, J Norden, K Pearce, E El-Gezawy, S Atarod, I Hromadnikova, M Collin, E Holler and A M Dickinson Bone Marrow Transplant 2016 51: 890; 10.1038/bmt.2016.125 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.